title: Letter to the editor re Mani et al.
authors.forename: Preet S
authors.initials: PS
authors.lastname: Chadha
authors.forename: Iain A
authors.initials: IA
authors.lastname: Greenwood
authors.forename: X Zoë
authors.initials: XZ
authors.lastname: Zhong
authors.forename: William C
authors.initials: WC
authors.lastname: Cole
mesh_terms: D000818:Animals; D000068579:Celecoxib; D051656:KCNQ Potassium Channels / Q000819:agonists*; D008297:Male; D009553:Nimodipine / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D020301:Vasospasm, Intracranial / Q000188:drug therapy*
chemical_list: D051656:KCNQ Potassium Channels; D011720:Pyrazoles; D013449:Sulfonamides; D014662:Vasoconstrictor Agents; D009553:Nimodipine; D000068579:Celecoxib